How monoclonal antibodies lost the fight with new COVID variants
Covid Lists
Study Shows How Paxlovid Resistance Emerges in Persistent Infections
“This type of approach helped to improve HIV drugs, and we think it’s a good way to improve antivirals against SARS-CoV-2,” says Sho Iketani, PhD, assistant professor of medical sciences at Columbia University’s Vagelos College of Physicians and Surgeons and Aaron Diamond AIDS Research Center, who co-led the research with David D. Ho, MD, the Clyde '56 and Helen Wu Professor of Medicine, professor of microbiology & immunology, and director of the Aaron Diamond AIDS Research Center, and Haitao Yang, PhD, of ShanghaiTech University.
Monoclonal antibody levels and protection from COVID-19
Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir
Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B
Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro
Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout | Clinical Infectious Diseases | Oxford Academic
Real-Time Whole Genome Sequencing to Guide Patient-Tailored Therapy of Severe Acute Respiratory Syndrome Coronavirus 2 Infection | Clinical Infectious Diseases | Oxford Academic
Luteolin: A promising natural agent in management of pain in chronic conditions
Luteolin
Pharmacological Activity of Eriodictyol: The Major Natural Polyphenolic Flavanone
Eriodictyol - an overview | ScienceDirect Topics
TREAT ME Survey: Individual Treatment Results
Lumbrokinase, a Fibrinolytic Enzyme, Prevents Intra-Abdominal Adhesion by Inhibiting the Migrative and Adhesive Activities of Fibroblast via Attenuation of the AP-1/ICAM-1 Signaling Pathway
Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome | Clinical Infectious Diseases | Oxford Academic
Fibrin drives thromboinflammation and neuropathology in COVID-19
Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2
Informing Blacks with Long Covid
Monoclonal Antibodies: A Potential Solution For Prolonged COVID Symptoms?
Long COVID: Some patients may need an immune system boost
Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab
Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: A report of signal index cases and call for targeted research
Taurine deficiency as a driver of aging
Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors
Berberine reduces circulating inflammatory mediators in patients with severe COVID-19 | British Journal of Surgery | Oxford Academic
Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
(16) Post-Viral Trials News (@postviraltrials) / X
Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial
Study Details | Antiviral Clinical Trial for Long Covid-19 | ClinicalTrials.gov
anticoagulant-triple-therapy.pdf
Archive - Studies, Surveys, & Supplements